Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms

B Lagerqvist1, C Sylvén, A Waldenström

  • 1Department of Internal Medicine, University Hospital, Uppsala, Sweden.

British Heart Journal
|September 1, 1992
PubMed

Insights

Patients with angina-like chest pain and normal coronary arteries are more sensitive to adenosine-induced chest pain. They experience pain at lower doses and have less tolerance, indicating a heightened pain response.

Area of Science:

  • Cardiology
  • Pain Research

Background:

  • Angina-like chest pain with normal coronary angiograms is a common clinical problem.
  • The underlying mechanisms for this condition are not fully understood.

Purpose of the Study:

  • To determine if patients with angina-like chest pain and normal coronary arteries exhibit increased sensitivity to adenosine-induced chest pain compared to patients with coronary stenoses and healthy controls.

Main Methods:

  • A single-blind study involving intravenous bolus injections of increasing adenosine doses.
  • Chest pain and electrocardiographic changes were monitored in three groups: patients with normal coronaries (group A), patients with coronary stenoses (group B), and healthy volunteers (group C).

Main Results:

  • Adenosine provoked angina-like pain in all patients in groups A and B, indistinguishable from their usual angina.
  • Group A patients reported chest pain at significantly lower adenosine doses (0.9 mg) than group B (3.1 mg) and group C (6.2 mg).
  • Maximum tolerable adenosine doses were also significantly lower in group A (4.7 mg) compared to group B (9.2 mg) and group C (12.0 mg).

Conclusions:

  • Patients experiencing angina-like chest pain despite normal coronary angiograms demonstrate a heightened sensitivity and reduced tolerance to adenosine-induced pain.
  • This suggests a potential hypersensitivity to adenosine or related pathways in this patient population.
Abstract

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...